Indivior Pharmaceuticals Inc
INDV
Rangering i aksjer
#4004
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Aksjekurs
$32.56
Sist synkronisert: 2026-10-16
Markedsverdi
$4.06B
Endring (1 dag)
-3.15%
Endring (1 år)
33.01%
Land
US
Handel Indivior Pharmaceuticals Inc (INDV)
Kategori
Healthcare
EPS for Indivior Pharmaceuticals Inc (INDV)
EPS per June 2026 TTM: $2.84
Ifølge de siste økonomiske rapportene og aksjekursen til Indivior Pharmaceuticals Inc er selskapets nåværende EPS (TTM) $2.84. Ved slutten av 2023 hadde selskapet en EPS på $0.01, en økning sammenlignet med EPS-en i 2022 som var $-0.37.
EPS-historikk for Indivior Pharmaceuticals Inc fra 2016 til 2026
EPS ved slutten av hvert år
| År | EPS | Endre |
|---|---|---|
| 2026 (TTM) | $2.84 | 14,100.00% |
| 2024 | $0.02 | 3.42% |
| 2023 | $0.01 | -103.95% |
| 2022 | $-0.37 | -126.81% |
| 2021 | $1.38 | -227.78% |
| 2020 | $-1.08 | -213.68% |
| 2019 | $0.95 | -47.51% |
| 2018 | $1.81 | 330.95% |
| 2017 | $0.42 | 90.91% |
| 2016 | $0.22 | 0.00% |
EPS for lignende selskaper eller konkurrenter
| Selskap | EPS | EPS-forskjell | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -80.41% |
IN
|
